SynthesisBioMed research international2021

Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Jie-Tao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.